At the VIVA 2026 conference, the SirPAD study showcases significant findings on femoropopliteal artery disease treatments, enhancing patient outcomes.

The SirPAD study at VIVA 2026 presents new insights on treating claudication due to femoropopliteal PAD, exploring the benefits of sirolimus-coated balloons.

Concept Medical revealed three-year follow-up data from the SIRONA trial at the Charing Cross Symposium 2026, showcasing significant advancements in drug delivery technologies.

Concept Medical presented encouraging preliminary findings from the 3-year follow-up of the SIRONA trial at the Charing Cross 2026 Symposium, spotlighting advancements in peripheral intervention therapies.

Concept Medical Inc. highlights significant findings from SIRONA trial at the Charing Cross Symposium 2026, showcasing its innovative balloon angioplasty technology.

Concept Medical's SirPAD trial demonstrates safety and efficacy of their sirolimus-coated balloon for treating peripheral artery disease, setting a new standard in vascular interventions.

Concept Medical Inc. announces successful completion of patient recruitment in the SirPAD trial, involving over 1,250 participants to assess sirolimus-coated balloons.

Concept Medical has successfully enrolled its first patient in the MAGICAL BTK clinical trial, a groundbreaking step towards enhancing treatment for peripheral artery disease in the U.S.

Concept Medical has successfully enrolled the first patient in its MAGICAL BTK IDE trial, aimed at transforming treatment for peripheral artery disease in the USA.